187 related articles for article (PubMed ID: 17249693)
1. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
[TBL] [Abstract][Full Text] [Related]
2. Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity.
Yamada T; Fialho AM; Punj V; Bratescu L; Gupta TK; Chakrabarty AM
Cell Microbiol; 2005 Oct; 7(10):1418-31. PubMed ID: 16153242
[TBL] [Abstract][Full Text] [Related]
3. Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening.
Toledo-Sherman L; Deretey E; Slon-Usakiewicz JJ; Ng W; Dai JR; Foster JE; Redden PR; Uger MD; Liao LC; Pasternak A; Reid N
J Med Chem; 2005 May; 48(9):3221-30. PubMed ID: 15857128
[TBL] [Abstract][Full Text] [Related]
4. Noncationic peptides obtained from azurin preferentially enter cancer cells.
Taylor BN; Mehta RR; Yamada T; Lekmine F; Christov K; Chakrabarty AM; Green A; Bratescu L; Shilkaitis A; Beattie CW; Das Gupta TK
Cancer Res; 2009 Jan; 69(2):537-46. PubMed ID: 19147567
[TBL] [Abstract][Full Text] [Related]
5. Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2.
Tanabe H; Kuribayashi K; Tsuji N; Tanaka M; Kobayashi D; Watanabe N
Int J Oncol; 2011 Jul; 39(1):33-40. PubMed ID: 21503576
[TBL] [Abstract][Full Text] [Related]
6. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
[TBL] [Abstract][Full Text] [Related]
7. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
[TBL] [Abstract][Full Text] [Related]
8. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
[TBL] [Abstract][Full Text] [Related]
9. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Huusko P; Ponciano-Jackson D; Wolf M; Kiefer JA; Azorsa DO; Tuzmen S; Weaver D; Robbins C; Moses T; Allinen M; Hautaniemi S; Chen Y; Elkahloun A; Basik M; Bova GS; Bubendorf L; Lugli A; Sauter G; Schleutker J; Ozcelik H; Elowe S; Pawson T; Trent JM; Carpten JD; Kallioniemi OP; Mousses S
Nat Genet; 2004 Sep; 36(9):979-83. PubMed ID: 15300251
[TBL] [Abstract][Full Text] [Related]
10. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.
Chrencik JE; Brooun A; Recht MI; Nicola G; Davis LK; Abagyan R; Widmer H; Pasquale EB; Kuhn P
J Biol Chem; 2007 Dec; 282(50):36505-13. PubMed ID: 17897949
[TBL] [Abstract][Full Text] [Related]
12. EphB2 and ephrin-B2 regulate the ionic homeostasis of vestibular endolymph.
Dravis C; Wu T; Chumley MJ; Yokoyama N; Wei S; Wu DK; Marcus DC; Henkemeyer M
Hear Res; 2007 Jan; 223(1-2):93-104. PubMed ID: 17158005
[TBL] [Abstract][Full Text] [Related]
13. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
[TBL] [Abstract][Full Text] [Related]
14. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss.
Du J; Tran T; Fu C; Sretavan DW
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5567-81. PubMed ID: 18055806
[TBL] [Abstract][Full Text] [Related]
16. ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.
Steiner L; Blum G; Friedmann Y; Levitzki A
Eur J Pharmacol; 2007 May; 562(1-2):1-11. PubMed ID: 17376430
[TBL] [Abstract][Full Text] [Related]
17. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
[TBL] [Abstract][Full Text] [Related]
18. Presenilin1/gamma-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk binding protein.
Georgakopoulos A; Xu J; Xu C; Mauger G; Barthet G; Robakis NK
FASEB J; 2011 Oct; 25(10):3594-604. PubMed ID: 21746865
[TBL] [Abstract][Full Text] [Related]
19. EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of medullary tubule cells through Rho family GTPases.
Ogawa K; Wada H; Okada N; Harada I; Nakajima T; Pasquale EB; Tsuyama S
J Cell Sci; 2006 Feb; 119(Pt 3):559-70. PubMed ID: 16443753
[TBL] [Abstract][Full Text] [Related]
20. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
